StemCell Institute
7096.TPharmaceutical
In English · 4
Mon, Mar 3 · JST1 filing
16:005% STAKEStemCell Institute · NIHON TRIM CO., LTD. · 72.06% → 70.02%−2.04ppAll EDINET filings · 45
| Filed | Document | Source |
|---|---|---|
| 2023-11-10 | Quarterly report | S100S77I |
| 2023-08-10 | Quarterly report | S100RLHP |
| 2023-06-26 | Internal control report | S100R3FD |
| 2023-06-26 | CEO/CFO certification | S100R3F5 |
| 2023-06-26 | Annual report | S100R2C5 |
| 2023-02-14 | Quarterly report | S100Q7X2 |
| 2022-11-11 | Quarterly report | S100PKG3 |
| 2022-08-10 | Quarterly report | S100OXRG |
| 2022-06-24 | Internal control report | S100OCYK |
| 2022-06-24 | CEO/CFO certification | S100OCXC |
| 2022-06-24 | Annual report | S100OD0Y |
| 2022-02-10 | Quarterly report | S100NFF7 |
| 2021-11-12 | Quarterly report | S100MUOM |
| 2021-08-11 | Quarterly report | S100M74S |
| 2021-06-30 | Annual report | S100LVGX |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 4 financial reports not structured yet.